Why the study?
Do fibrates reduce mortality in patients requiring primary or secondary prevention of coronary artery disease?
Do fibrates reduce mortality in patients requiring primary or secondary prevention of coronary artery disease?
Fibrates are safe to use in combination with statins but lack mortality benefit, confirming their role as second-line lipid-lowering agents.
No takes yet. Share an insight, caveat, or question.
Supports second-line use with statins; confirms limited role from RCT evidence.
Remick et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: